" Kaohsiung Medical University Chung-Ho Memorial Hospital" was approved by the TFDA for treating patients with "Stage I to III solid cancer after ineffective conventional treatment" by autologous dendritic cell therapy on February 13, 2020
" Kaohsiung Medical University Chung-Ho Memorial Hospital " is one of the Ever Supremes’ collaborating medical institutes. It received approval by the Taiwan FDA for treating patients with "Stage I to III solid cancer after ineffective conventional treatment" by autologous dendritic cell (DC) therapy. Patients qualified to be admitted for relevant treatment includes indication such as breast cancer.